Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Confronting Inequities in Immuno-Oncology Care

Credits Available
Pharmacists: 1.0 contact hour (0.1 CEUs)
Released: June 16, 2022 Expiration: June 15, 2023
Start Activity
Provided by ProCE, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by education grants from
Bristol-Myers Squibb
Merck Sharp & Dohme Corp.
Jessica Davis, PharmD
Kamakshi V. Rao, PharmD, BCOP, FASHP

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Identify patient populations and social determinants of health that increase risk for poor prognosis secondary to health disparities
  • Discuss management of immune-related adverse events in patient groups affected by inequalities and poor healthcare access
  • Incorporate health disparity mitigation strategies into the care of all patients receiving immune checkpoint inhibitor therapy and experiencing immune-related adverse events
  • Describe education, quality improvement, and other support strategies to ensure patients with cancer receive optimal and equitable care

Information on this Educational Activity

ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty

Jessica Davis, PharmD

Clinical Pharmacist Coordinator
Department of Adult Hematology/Oncology
Levine Cancer Institute, Atrium Health
Charlotte, North Carolina

Jessica Michaud Davis, PharmD, BCOP, CPP, has disclosed that she has received consulting fees from Array, Exelixis, and Regeneron/Sanofi.
Kamakshi V. Rao, PharmD, BCOP, FASHP

Assistant Director
Department of Pharmacy
University of North Carolina Medical Center
Adjunct Professor of Clinical Education
Division of Practice Advancement and Clinical Education
UNC Eshelman School of Pharmacy
Chapel Hill, North Carolina

Kamakshi V. Rao, PharmD, BCOP, FASHP, has no relevant conflicts of interest to report.

Staff

Megan Cartwright, PhD

Senior Clinical Editor

Megan Cartwright, PhD, has no relevant conflicts of interest to report.
Timothy A. Quill, PhD

Vice President, Scientific Services

Timothy Quill, PhD, has no relevant conflicts of interest to report.
Jamie Sebaaly

Director, Educational Strategy

Jamielynn Sebaaly, PharmD, BCPS, has no relevant conflicts of interest to report.
Jason Everly, PharmD

Director, Program Development and Educational Impact

Jason J. Everly, PharmD, BCOP, CHCP, has no relevant conflicts of interest to report.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

The target audience for this activity is pharmacists, including managed care, specialty, and clinical pharmacists, who care for patients with cancer as well as pharmacy directors, chief pharmacy officers, and other stakeholders in pharmacy practice.

Goal

The goal of this activity is to improve the knowledge and competence of learners in providing inclusive and equitable care for all patients with cancer, including those patients eligible for or receiving immunotherapy.

Continuing Pharmacy Education

ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-0000-22-187-H01-P has been assigned to this home study, application-based activity. This activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Completion of an evaluation and post-test with a score of 65% or higher is required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from June 16, 2022, through June 15, 2023:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Confronting Inequities in Immuno-Oncology Care

Loading...
Watch this on-demand webcast of a live webinar for expert discussion of how pharmacists can implement patient–, provider–, and health system– level strategies to mitigate health disparities in the care of patients receiving immune checkpoint inhibitors.
Jessica Davis, PharmD
Kamakshi V. Rao, PharmD, BCOP, FASHP
Pharmacists: 1.0 contact hour (0.1 CEUs)
Released: June 16, 2022 Expiration: June 15, 2023

Related Content

Expert slides for pharmacists on strategies to overcome health inequities with immune checkpoint inhibitors, from Clinical Care Options (CCO)

Jessica Davis, PharmD Kamakshi V. Rao, PharmD, BCOP, FASHP Released: June 8, 2022

Expert-selected slides on chronic lymphocytic leukemia with a pharmacy perspective to help treat your patients with CLL, from ProCE and Clinical Care Options (CCO).

Lydia Benitez, PharmD, BCOP Caitlin R. Rausch, PharmD Released: May 18, 2022

In slides from Clinical Care Options (CCO), expert pharmacists provide insights on the use of novel systemic therapies for HCC

Courtney C. Cavalieri, PharmD, BCOP Amber Draper, PharmD, BCOP Released: May 18, 2022

Experts discuss current and emerging oral targeted therapies in early and advanced HR+/HER2- breast cancer, from Clinical Care Options (CCO)

Allison Butts, PharmD, BCOP Kristina F. Byers, PharmD, BCOP Pharmacists: 1.0 contact hour (0.1 CEUs) Released: May 3, 2022 Expired: May 2, 2023
Provided by ProCE, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by education grants from
Bristol-Myers Squibb
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings